Citius Oncology, Inc. (CTOR) Return on equity
Citius Oncology, Inc. (CTOR) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to CTORSource: SEC XBRL filings · For reference only · Not investment advice
More CTOR financial trends
CTOR RevenueCTOR Net incomeCTOR Net marginCTOR Gross profitCTOR Gross marginCTOR Operating incomeCTOR Operating marginCTOR Operating cash flowCTOR Free cash flowCTOR Capital expendituresCTOR Stock buybacksCTOR Dividends paidCTOR Total assetsCTOR Total liabilitiesCTOR Shareholders’ equityCTOR overview →